Effective inhibition of dengue virus replication using 3′UTR-targeted Vivo-Morpholinos

Effective inhibition of dengue virus replication using 3′UTR-targeted Vivo-Morpholinos

IntroductionDue to the impact of antibody-dependent enhancement and viral variation, effective vaccines or antiviral therapies remain lacking for the dengue virus (DENV). Nucleic acid drugs, particularly Vivo-Morpholinos (MOs), have emerged as a promising avenue for antiviral treatment due to their...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengwei Niu, Wenyanbo Yi, Zhuofan Dong, Xiaofeng Li, Xue Dong, Lifang Yu, Yao Han, Oujia Zhang, Ziyang Sheng, Jing An, Hao Li, Yansong Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Immunology
Subjects:	antisense oligonucleotides antiviral dengue virus (DENV) antisense therapy nucleic acid therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1491230/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney
by: Toshiki Tsuboi, et al.
Published: (2025-03-01)

Unveiling sequence-agnostic mixed-chemical modification patterns for splice-switching oligonucleotides using the NATURA platform
by: Tommaso Tabaglio, et al.
Published: (2025-03-01)

Nucleic acid therapeutics: Past, present, and future
by: Sajid Naeem, et al.
Published: (2025-03-01)

Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01)

Discovery and characterization of stereodefined PMO-gapmers targeting tau
by: Kunihiko Kanatsu, et al.
Published: (2025-03-01)

Therapeutics in paediatric genetic diseases: current and future landscape
by: Ai Ling Koh, et al.
Published: (2023-01-01)

Targeting splicing for hematological malignancies therapy
by: Monika Szelest, et al.
Published: (2024-11-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Changes induced in mouse lipid metabolism by simultaneous impact of antisense oligonucleotide derivatives to <i>apoB</i>, <i>PCSK9</i>, and <i>apoCIII</i> mRNAs
by: S. I. Oshevski, et al.
Published: (2020-01-01)

Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma
by: Alexandre Khuu, et al.
Published: (2024-11-01)

Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder
by: Inna Shomer, et al.
Published: (2025-03-01)

RNA therapeutics in the clinic
by: Alexander Curreri, et al.
Published: (2023-01-01)

Therapeutic landscape for inherited ocular diseases: current and emerging therapies
by: Hwei Wuen Chan, et al.
Published: (2023-01-01)

Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids
by: Randall Allen, et al.
Published: (2024-12-01)

RNA structure in alternative splicing regulation: from mechanism to therapy
by: Bao Nengcheng, et al.
Published: (2024-07-01)

Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington’s Disease
by: Sergio Adrian Ocampo-Ortega, et al.
Published: (2024-12-01)

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression
by: Young Hoon Jung, et al.
Published: (2024-10-01)

Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
by: Kohshi Kusumoto, et al.
Published: (2025-01-01)

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
by: Kaili Ou, et al.
Published: (2025-01-01)

Estimation and Characterization of Dengue Serotypes in Patients Presenting with Dengue Fever at Makkah Hospitals
by: Sami Melebari, et al.
Published: (2025-01-01)

RNA diagnostics and therapeutics: a comprehensive review
by: Adeela Fathima Saju, et al.
Published: (2025-12-01)

Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
by: Michael L. McCaleb, et al.
Published: (2025-03-01)

Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management
by: Bhargav Shreevatsa, et al.
Published: (2025-02-01)

Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy
by: Hüseyin Bahadır Şenol, et al.
Published: (2025-01-01)

Golodirsen restores DMD transcript imbalance in Duchenne Muscular Dystrophy patient muscle cells
by: Rachele Rossi, et al.
Published: (2024-11-01)

The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations
by: Pushkar Malakar, et al.
Published: (2024-12-01)

Characterizing the plasma protein binding profiles of chemistry diversified antisense oligonucleotides in human and mouse plasma using an ultrafiltration method
by: Cassandra Yun, et al.
Published: (2025-01-01)

GENOTYPIC DIVERSITY OF DENGUE VIRUS IN AEDES MOSQUITOES COLLECTED FROM DENGUE HOTSPOT AREAS IN KUALA LUMPUR AND SELANGOR, MALAYSIA
by: Wan Najdah Wan Mohamad Ali, et al.
Published: (2023-04-01)

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
by: Olga Golounina, et al.
Published: (2025-01-01)

Therapeutic approaches for repeat expansion diseases: a comprehensive review
by: Afsana Bhuiyan
Published: (2024-12-01)

Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders
by: Yasir Qasim Almajidi, et al.
Published: (2025-01-01)

Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA
by: Anastasiya Oshchepkova, et al.
Published: (2024-10-01)

Landscape of antisense genes in the human genome and identification of new human hepatic antisense RNAs by long-read sequencing
by: Juan Jose Rojo-Carrillo, et al.
Published: (2024-11-01)

A REVIEW ON FUTURE PERSPECTIVES IN TARGETING THE RNA CAPPING IN DENGUE VIRUS BY NS5 METHYLTRANSFERASE
by: Kapil Vashisht, et al.
Published: (2023-04-01)

Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation
by: Massimiliano Fonsi, et al.
Published: (2024-01-01)

Anti-DENV-ED3 antibody cross-talks generate immune interference among the four DENVs
by: Md. Din Islam, et al.
Published: (2024-12-01)

Cocirculation of 4 Dengue Virus Serotypes, Putumayo Amazon Basin, 2023–2024
by: Jacob van der Ende, et al.
Published: (2025-01-01)

A novel metal‐organic framework encapsulated iridium oxide nanozyme enhanced antisense oligonucleotide combo for osteoarthritis synergistic therapy
by: Shuqi Wu, et al.
Published: (2024-12-01)

The 2023 dengue outbreak in Lombardy, Italy: A one-health perspective
by: Francesca Rovida, et al.
Published: (2025-03-01)

A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination
by: Roberto Dias de Oliveira, et al.
Published: (2024-11-01)